TMED vs IDNA

ATMED

BIDNA

Measures won2–2level · of 6 · 5Y

$10,000 · 5Y$8,930IDNA

Lowest cost0.44%TMED · $44 on $10k

Most income0.66%IDNA · $66 on $10k

Smallest drop−10.6%IDNA · worst fall in 1Y

Held in common1.8%TMED and IDNA

TMED

IDNA

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF · $35MiShares Genomics Immunology and Healthcare ETF · $335M

[…]3 years · per year[…] · $23,890+33.7%

[…]5 years · per year[…] · $8,930−2.2%

0.44%Expense ratio$44 · $47 on $10k · lower wins0.47%

0.47%12-mo yield$47 · $66 on $10k0.66%

−11.1%Worst dropSmaller wins−10.6%

19.4%VolatilityLower wins30.6%

2–2Level

$10,000 · 5 yearsOne scale

Shared top holdingsTMED · IDNA

0.7%BNTX2.8%

0.4%CRVS0.5%

0.4%INCY3.2%

0.9%PRME0.1%

Held in common1.8%

End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

Both

5Y2 funds

#			Trend
1	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.66%	+2.1%	+62.2%	+71.4%	+33.7%	−2.2%	−10.6%	$335M
2	ATMED	T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFRead Desk		0.44%	0.47%	+1.4%	+15.2%	+21.3%	new	new	−11.1%	$35M

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Both

5Y2 funds

#			Trend
1	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.66%	+2.1%	+62.2%	+71.4%	+33.7%	−2.2%	−10.6%	$335M
2	ATMED	T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFRead Desk		0.44%	0.47%	+1.4%	+15.2%	+21.3%	new	new	−11.1%	$35M

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

TMED vs IDNA

TMED

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care

[…]

IDNA

iShares Genomics Immunology and Healthcare

$8,930

MeasureTMEDIDNA

Fee0.44%0.47%

Cost on $10k a year$44$47

Yield0.47%0.66%

5 years, per year[…]−2.2%

3 years, per year[…]+33.7%

Worst drop · 1Y−11.1%−10.6%

Volatility · 1Y19.4%30.6%

2–2measures won
level

1.8%

holdings shared

Nov 6, 2026 · $10,000 five years ago, dividends reinvested

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+3.2%

JEPIJ.P. Morgan

+5.3%

+3.2%Year to date+5.3%

12.8%Yield8.1%

$42.6BAssets$46.8B

1–1level

End-of-day Nov 6, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.8%

SPYSPDR

+8.7%

+8.8%Year to date+8.7%

1.1%Yield1.0%

$182BAssets$819B

2–0SPYM wins

End-of-day Nov 6, 2026

Overlap: TMED, IDNA

Today

1.8%most shared, TMED and IDNA

TMEDIDNA

TMED—1.8%

IDNA1.8%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$19most kept, IDNA

IDNA$66 − $47 = $19

TMED$47 − $44 = $3

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee